Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CP+ Associates is a private Swiss social venture and consultancy focused on strengthening health-related scientific capacity and capability in low- and middle-income countries, particularly in Africa. Rather than developing proprietary therapeutics, the organization supports medicine discovery, development, regulation, clinical trials, and clinical pharmacology through open-access educational programs, fellowships, workshops, and advisory services. Its work appears centered on global health workforce development, pharmacometrics training, and clinical pharmacology capability building in partnership with academic groups, research organizations, and funders. Publicly visible partners and supporters include the Gates Foundation, Makerere University's Infectious Diseases Institute, H3D-related organizations, TASK, and PMX Africa. For a biotech analyst, CP+ Associates is best understood as a health-focused capability-building and consulting organization adjacent to drug development rather than a biotech product company with a therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CP+ Associates.